S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
NASDAQ:EYEG

EyeGate Pharmaceuticals News Headlines

$1.91
-0.19 (-9.05 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.87
$2.04
50-Day Range
$1.48
$3.77
52-Week Range
$1.44
$8.18
Volume1.84 million shs
Average Volume825,222 shs
Market Capitalization$24.10 million
P/E RatioN/A
Dividend YieldN/A
Beta1.1

Media Mentions By Week

EyeGate Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EYEG
News Sentiment

0.42

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EYEG Articles
This Week

0

0

EYEG Articles
Average Week

Get EyeGate Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYEG and its competitors with MarketBeat's FREE daily newsletter.

EyeGate Pharmaceuticals (NASDAQ EYEG) News Headlines Today

SourceHeadline
EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) Short Interest UpdateEyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) Short Interest Update
americanbankingnews.com - September 18 at 12:08 PM
 Analysts Expect EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) Will Announce Earnings of -$0.29 Per Share Analysts Expect EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) Will Announce Earnings of -$0.29 Per Share
americanbankingnews.com - September 17 at 9:12 PM
Thinking about buying stock in SeaChange, SmileDirectClub, Li-Cycle, Wheels Up, or Eyegate Pharmaceuticals?Thinking about buying stock in SeaChange, SmileDirectClub, Li-Cycle, Wheels Up, or Eyegate Pharmaceuticals?
benzinga.com - September 14 at 4:57 PM
EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceEyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 9 at 6:23 PM
EyeGate Pharmaceuticals (NASDAQ:EYEG) Rating Reiterated by HC WainwrightEyeGate Pharmaceuticals (NASDAQ:EYEG) Rating Reiterated by HC Wainwright
americanbankingnews.com - September 9 at 12:55 PM
EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for the Treatment of Ocular Surface InflammationEyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for the Treatment of Ocular Surface Inflammation
finance.yahoo.com - September 8 at 7:05 AM
EyeGate Pharma Reports Second Quarter 2021 Financial Results and Provides Business UpdateEyeGate Pharma Reports Second Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - August 12 at 5:57 PM
EyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesEyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
finance.yahoo.com - August 11 at 8:27 PM
EyeGate Shares Drop After $10.75M Direct Stock Offering PricesEyeGate Shares Drop After $10.75M Direct Stock Offering Prices
marketwatch.com - August 10 at 1:10 PM
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesEyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
finance.yahoo.com - August 10 at 8:10 AM
EyeGate Pharmaceuticals Shares Drop 11% After Tuesday RiseEyeGate Pharmaceuticals Shares Drop 11% After Tuesday Rise
marketwatch.com - July 28 at 1:34 PM
EyeGate Pharma Shares Up 67% on Buyout Offer, New CEOEyeGate Pharma Shares Up 67% on Buyout Offer, New CEO
marketwatch.com - July 27 at 2:21 PM
Why Eyegate Pharmaceuticals Shares Are Skyrocketing TodayWhy Eyegate Pharmaceuticals Shares Are Skyrocketing Today
benzinga.com - July 27 at 2:21 PM
EyeGate Skyrockets After It Names a New CEO and Plans for an AcquisitionEyeGate Skyrockets After It Names a New CEO and Plans for an Acquisition
finance.yahoo.com - July 27 at 2:21 PM
5 Top Stock Gainers for Tuesday: SiriusXM, Fiserv, EyeGate5 Top Stock Gainers for Tuesday: SiriusXM, Fiserv, EyeGate
finance.yahoo.com - July 27 at 2:21 PM
BRIEF-EyeGate Pharma Reports Appointment of Brian M. Strem as President and CEOBRIEF-EyeGate Pharma Reports Appointment of Brian M. Strem as President and CEO
msn.com - July 26 at 6:43 PM
Why Shares Of Eyegate Pharmaceuticals Spiked After Hours MondayWhy Shares Of Eyegate Pharmaceuticals Spiked After Hours Monday
msn.com - July 26 at 6:43 PM
EyeGate Pharma Names New Pres, CEO, Plans to Acquire Bayon TherapeuticsEyeGate Pharma Names New Pres, CEO, Plans to Acquire Bayon Therapeutics
marketwatch.com - July 26 at 6:43 PM
Eyegate Pharmaceuticals, Inc. Common Stock (EYEG)Eyegate Pharmaceuticals, Inc. Common Stock (EYEG)
nasdaq.com - July 16 at 7:16 PM
Where Do Hedge Funds Stand On Eyegate Pharmaceuticals, Inc. (EYEG)?Where Do Hedge Funds Stand On Eyegate Pharmaceuticals, Inc. (EYEG)?
finance.yahoo.com - June 30 at 2:32 PM
EyeGate Pharma Stock Jumps On Initiation Of Proof Of Concept Trial With DHODH Inhibitor In Ophthalmology IndicationsEyeGate Pharma Stock Jumps On Initiation Of Proof Of Concept Trial With DHODH Inhibitor In Ophthalmology Indications
msn.com - June 17 at 12:35 AM
EyeGate Pharmaceuticals Doses First Patient in Ocular Disease StudyEyeGate Pharmaceuticals Doses First Patient in Ocular Disease Study
marketwatch.com - June 14 at 8:43 AM
EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation StudyEyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study
finance.yahoo.com - June 14 at 8:43 AM
EYEG: Maturing and evolvingEYEG: Maturing and evolving
finance.yahoo.com - May 18 at 12:11 PM
EyeGate Pharma Reports First Quarter 2021 Financial Results and Provides Business UpdateEyeGate Pharma Reports First Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - May 12 at 5:49 PM
EyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of DirectorsEyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of Directors
finance.yahoo.com - April 1 at 7:23 AM
MAIA Biotechnology to Present at Upcoming Investor ConferencesMAIA Biotechnology to Present at Upcoming Investor Conferences
ca.finance.yahoo.com - March 27 at 5:57 PM
EyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business UpdateEyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business Update
finance.yahoo.com - March 25 at 7:51 PM
EyeGate Pharmaceuticals Announces Management Transition In Support of Strategic TransformationEyeGate Pharmaceuticals Announces Management Transition In Support of Strategic Transformation
finance.yahoo.com - February 1 at 7:46 AM
Ocular Drug Delivery Market May See a Big Move : Major Giants Allergan, EyeGate Pharma, Bausch Health, Graybug VisionOcular Drug Delivery Market May See a Big Move : Major Giants Allergan, EyeGate Pharma, Bausch Health, Graybug Vision
marketwatch.com - January 30 at 8:11 AM
EyeGate Enters Into Agreement for $8.0 Million Private PlacementEyeGate Enters Into Agreement for $8.0 Million Private Placement
finance.yahoo.com - January 6 at 7:34 AM
EYEG: Expanding the pipelineEYEG: Expanding the pipeline
finance.yahoo.com - December 30 at 5:32 PM
Analyzing The Price Action In Eyegate Pharmaceuticals Stock TodayAnalyzing The Price Action In Eyegate Pharmaceuticals Stock Today
msn.com - December 21 at 3:26 PM
Biopharma M&A Continues: Agios Sells Oncology Portfolio, NantKwests Reverse Merger With ImmunityBio, Eyegate Picks Up PanoptesBiopharma M&A Continues: Agios Sells Oncology Portfolio, NantKwest's Reverse Merger With ImmunityBio, Eyegate Picks Up Panoptes
markets.businessinsider.com - December 21 at 10:25 AM
Stock Alert: EyeGate Pharmaceuticals Soars Above 75%Stock Alert: EyeGate Pharmaceuticals Soars Above 75%
markets.businessinsider.com - December 21 at 10:25 AM
Ocular Inflammation Treatment Market Research 2020-2025: Market Analysis, Drivers, Restraints, Opportunities, and ThreatsOcular Inflammation Treatment Market Research 2020-2025: Market Analysis, Drivers, Restraints, Opportunities, and Threats
theglobeandmail.com - December 17 at 2:47 PM
EYEG: Looking Ahead to 2021EYEG: Looking Ahead to 2021
finance.yahoo.com - November 30 at 3:30 PM
Uveitis Treatment Market is estimated to reach $1,142 million by 2024; growing at a CAGR of 7.5% from 2020 to 2024Uveitis Treatment Market is estimated to reach $1,142 million by 2024; growing at a CAGR of 7.5% from 2020 to 2024
marketwatch.com - November 29 at 1:52 AM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reports Third Quarter 2020 Financial Results and Provides Business UpdateEyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reports Third Quarter 2020 Financial Results and Provides Business Update
finanznachrichten.de - November 9 at 7:27 PM
EyeGate Pharma Reports Third Quarter 2020 Financial Results and Provides Business UpdateEyeGate Pharma Reports Third Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 9 at 7:27 PM
EYEG: Raising Target on positive pipeline progressEYEG: Raising Target on positive pipeline progress
finance.yahoo.com - October 12 at 4:54 AM
How Much Does EyeGate Pharmaceuticals' (NASDAQ:EYEG) CEO Make?How Much Does EyeGate Pharmaceuticals' (NASDAQ:EYEG) CEO Make?
finance.yahoo.com - September 25 at 7:27 PM
Ocular Inflammation Treatment Market Report Reviews Drivers, Analysis, Share, Growth, Trends & Forecast to 2026Ocular Inflammation Treatment Market Report Reviews Drivers, Analysis, Share, Growth, Trends & Forecast to 2026
marketwatch.com - September 11 at 7:21 AM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma to Present at H.C. Wainwright 22nd Annual Global Investment ConferenceEyeGate Pharmaceuticals, Inc.: EyeGate Pharma to Present at H.C. Wainwright 22nd Annual Global Investment Conference
finanznachrichten.de - September 8 at 8:48 AM
EyeGate Pharma to Present at H.C. Wainwright 22nd Annual Global Investment ConferenceEyeGate Pharma to Present at H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 8 at 8:48 AM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma Confirms Path Forward with FDA To Develop Combination ProductEyeGate Pharmaceuticals, Inc.: EyeGate Pharma Confirms Path Forward with FDA To Develop Combination Product
finanznachrichten.de - August 12 at 9:23 AM
EyeGate Pharma rallies 67% on development path for conjunctivitis treatmentEyeGate Pharma rallies 67% on development path for conjunctivitis treatment
seekingalpha.com - August 12 at 9:23 AM
EyeGate Pharma Confirms Path Forward with FDA To Develop Combination ProductEyeGate Pharma Confirms Path Forward with FDA To Develop Combination Product
finance.yahoo.com - August 12 at 9:23 AM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reports Second Quarter 2020 Financial Results and Provides Business UpdateEyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reports Second Quarter 2020 Financial Results and Provides Business Update
finanznachrichten.de - August 6 at 8:46 PM
EyeGate Pharma Reports Second Quarter 2020 Financial Results and Provides Business UpdateEyeGate Pharma Reports Second Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - August 6 at 8:46 PM
Get EyeGate Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYEG and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.